The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Antimicrobial resistance: the example of Staphylococcus aureus
Open accessAbstract
Nonstandard abbreviations used: methicillin-resistant Staphylococcus aureus (MRSA); staphylococcal cassette chromosome mec (SCCmec); methicillin-susceptible S. aureus (MSSA); penicillin-binding protein (PBP); quinolone resistance-determining region (QRDR); minimal inhibitory concentration (MIC); vancomycin intermediate-resistant S. aureus (VISA); vancomycin-resistant S. aureus (VRSA). SCIENCE IN MEDICINEFigure 1 S. aureus infections in intensive care units in the National Nosocomial Infections Surveillance System.Data include the total number of infections from 1987 to 1997.Isolates were tested for sensitivity to the following antimicrobial agents: gentamicin, tobramycin, amikacin, ciprofloxacin, clindamycin, erythromycin, chloramphenicol, trimethoprim-sulfamethoxazole, and vancomycin.Some hospitals did not test for all of the antibiotics.Reproduced with permission from New England Journal of Medicine (4).A Examples of several of the S. aureus mechanisms of resistance to selected antibiotics (77, 95-97).Pl, plasmid; C, chromosome; Tn, transposon; QRDR, quinolone resistance-determining region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fluoroquinolone resistance in S. aureus is caused by mutational changes in the gyrA and gyrB (topoisomerase II) and parC (grlA) and are (topoisomerase IV) genes.”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Self-citationSystem, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122108599 · Cited by 1,588
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,304
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,127
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community
Okuma, K., Iwakawa, K., Turnidge, J. D., Grubb, W. B., Bell, J. M., O'Brien, F. G., Coombs, G. W., Pearman, J. W., Tenover, F. C., Kapi, M., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4289-4294.2002 · Cited by 888
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02175-8 · Cited by 825
Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections
Perl, T. M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D., Twombley, J., French, P. P., & Herwaldt, L. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003069 · Cited by 799
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Sieradzki, K., Roberts, R. B., Haber, S. W., & Tomasz, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400704 · Cited by 638
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
(2001) · American Journal of Infection Control · doi:10.1067/mic.2001.119952 · Cited by 559
Cellbenin-resistant staphylococci.
Jevons, M. P. (1961) · Medical Entomology and Zoology · Cited by 555
Lina, G., Quaglia, A., Reverdy, M.-E., Leclercq, R., Vandenesch, F., & Etienne, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1062 · Cited by 548
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. M. M. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
Staphylococcus aureus Nasal Carriage and Infection in Patients on Hemodialysis
Yu, V. L., Goetz, A., Wagener, M., Smith, P. B., Rihs, J. D., Hanchett, J., & Zuravleff, J. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607103150204 · Cited by 475
Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis
Shinefield, H., Black, S., Fattom, A., Horwith, G., Rasgon, S., Ordonez, J., Yeoh, H., Law, D., Robbins, J. B., Schneerson, R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011297 · Cited by 474
Mazmanian, S. K., Liu, G., Jensen, E. R., Lenoy, E., & Schneewind, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080520697 · Cited by 453
Ito, T., Katayama, Y., & Hiramatsu, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1449 · Cited by 450
Lim, D., & Strynadka, N. C. J. (2002) · Nature Structural Biology · doi:10.1038/nsb858 · Cited by 442
Fitzgerald, J. R., Sturdevant, D. E., Mackie, S. M., Gill, S. R., & Musser, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161098098 · Cited by 434
Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop
Tomasz, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301725 · Cited by 418
Resistance of Staphylococcus aureus to the Action of Penicillin.
Rammelkamp, C. H., & Maxon, T. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-51-13986 · Cited by 416
Evidence for a Clonal Origin of Methicillin Resistance in Staphylococcus aureus
Kreiswirth, B., Kornblum, J., Arbeit, R. D., Eisner, W., Maslow, J. N., McGeer, A., Low, D. E., & Novick, R. P. (1993) · Science · doi:10.1126/science.8093647 · Cited by 409
Hanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
Utsui, Y., & Yokota, T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.397 · Cited by 365
Groom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360
Fey, P. D., Saïd-Salim, B., Rupp, M. E., Hinrichs, S. H., Boxrud, D. J., Davis, C. C., Kreiswirth, B. N., & Schlievert, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.196-203.2003 · Cited by 352
What determines nasal carriage of Staphylococcus aureus?
Peacock, S. J., de Silva, I., & Lowy, F. D. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02254-5 · Cited by 349
Self-citationFridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344
Cheung, A. L., Eberhardt, K. J., Chung, E., Yeaman, M. R., Sullam, P. M., Ramos, M., & Bayer, A. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117530 · Cited by 327
Crisóstomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., & de Lencastre, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161272898 · Cited by 322
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D. (1999) · Science · doi:10.1126/science.284.5413.507 · Cited by 318
Song, M. D., Wachi, M., Doi, M., Ishino, F., & Matsuhashi, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80373-3 · Cited by 302
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152773365 · Cited by 301
Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci
Tomasz, A., Nachman, S., & Leaf, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.124 · Cited by 291
Staphylococcus aureus resistant to vancomycin--United States, 2002.
(2002) · PubMed · Cited by 289
Prospective Study of 114 Consecutive Episodes of Staphylococcus aureus Bacteremia
Mylotte, J. M., McDermott, C., & Spooner, J. A. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.5.891 · Cited by 287
Historical Yearly Usage of Vancomycin
Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1303 · Cited by 276
Jessen, O., Rosendal, K., Bülow, P., Faber, V., & Eriksen, K. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909182811201 · Cited by 259
A Proteolytic Transmembrane Signaling Pathway and Resistance to β-Lactams in Staphylococci
Zhang, H. Z., Hackbarth, C. J., Chansky, K. M., & Chambers, H. F. (2001) · Science · doi:10.1126/science.1055144 · Cited by 252
Methicillin-Resistant Staphylococcus aureus as a Community Organism
Moreno, F., Crisp, C., Jorgensen, J. H., & Patterson, J. E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1308 · Cited by 239
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Vancomycin-Resistant Staphylococcus aureus--Pennsylvania, 2002
(2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.17.2116 · Cited by 228
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1345 · Cited by 226
Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus
Etz, H., Minh, D. B., Henics, T., Dryla, A., Winkler, B., Triska, C., Boyd, A. P., Söllner, J., Schmidt, W., von Ahsen, U., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092569199 · Cited by 218
The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
Walsh, T. R., & Howe, R. A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160806 · Cited by 215
(1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1566 · Cited by 209
Hiramatsu, K. (1995) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1995.tb02239.x · Cited by 206
SKINNER, D. (1941) · Archives of Internal Medicine · doi:10.1001/archinte.1941.00200110003001 · Cited by 192
Ubiquitous Presence of a mecA Homologue in Natural Isolates of Staphylococcus sciuri
Couto, I., de LENCASTRE, H., Severina, E., Kloos, W., Webster, J. A., Hubner, R. J., Sanches, I. S., & Tomasz, A. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.377 · Cited by 185
Use of Antimicrobial Agents and Drug Resistance
Swartz, M. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370709 · Cited by 178
Hanaki, H., Labischinski, H., Inaba, Y., Kondo, N., Murakami, H., & Hiramatsu, K. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.3.315 · Cited by 173
Origin and evolution of DNA associated with resistance to methicillin in staphylococci
Archer, G. L., & Niemeyer, D. M. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90608-4 · Cited by 172
Inactivated pbp4 in Highly Glycopeptide-resistant Laboratory Mutants of Staphylococcus aureus
Sieradzki, K., Pinho, M. G., & Tomasz, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18942 · Cited by 153
Climo, M. W., Patron, R. L., Goldstein, B. P., & Archer, G. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1355 · Cited by 151
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
Høiby, N., Jarløv, J. O., Kemp, M., Tvede, M., Bangsborg, J., Kjerulf, A., Pers, C., & Hansen, H. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09229-x · Cited by 141
Penicillin Resistant Staphylococci
Bondi, A., & Dietz, C. C. (1945) · Experimental Biology and Medicine · doi:10.3181/00379727-60-15089 · Cited by 128
Studies of the repressor (BlaI) of β‐lactamase synthesis in Staphylococcus aureus
Gregory, P. D., Lewis, R. A., Curnock, S. P., & Dyke, K. G. H. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4051770.x · Cited by 126
New (and not so new) antibacterial targets – from where and when will the novel drugs come?
Projan, S. J. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00197-2 · Cited by 122
Hiramatsu, K., Okuma, K., Xue, X., Yamamoto, M., Hori, S., & Kapi, M. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200208000-00009 · Cited by 121
Bisognano, C., Vaudaux, P. E., Rohner, P., Lew, D. P., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1428-1437.2000 · Cited by 119
Niemeyer, D. M., Pucci, M. J., Thanassi, J. A., Sharma, V. K., & Archer, G. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.18.5464-5471.1996 · Cited by 112
Antimicrobials: new solutions badly needed
Projan, S. J. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00364-8 · Cited by 110
Expression of resistance to methicillin
Berger‐Bächi, B. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90617-3 · Cited by 106
Couto, I., Wu, S. W., Tomasz, A., & de LENCASTRE, H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.2.645-653.2003 · Cited by 99
Richards, C. L., Emori, T. G., Edwards, J. R., Fridkin, S. K., Tolson, J. S., & Gaynes, R. P. (2001) · American Journal of Infection Control · doi:10.1067/mic.2001.118408 · Cited by 96
Efficacy of antibiotic prophylaxis
Savitz, M. H. (1989) · Neurosurgery · doi:10.1097/00006123-198908000-00026 · Cited by 76
Allignet, J., Aubert, S., Morvan, A., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2523 · Cited by 63
mecA - blaZ Corepressors in Clinical Staphylococcus aureus Isolates
Rosato, A. E., Kreiswirth, B. N., Craig, W. A., Eisner, W., Climo, M. W., & Archer, G. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1460-1463.2003 · Cited by 63
Michie, C. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02270-6 · Cited by 16
Cited by
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Antibiotics in the aquatic environments: A review of the European scenario
Carvalho, I. T., & Santos, L. (2016) · Environment International · doi:10.1016/j.envint.2016.06.025 · Cited by 1,324
Klein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862
Metadata
- Authors
- Lowy, F. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-01
- Volume
- 111
- Issue
- 9
- Pages
- 1265-1273
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2157177676
- Cited by
- 1,445
- References
- 90
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.